Chemical Coordination and Integration · Lesson 7 of 11
Pancreatic Islets: Insulin, Glucagon and Diabetes Mellitus
“Explain endocrine pancreatic islets and how insulin and glucagon counterregulate blood glucose and relate to diabetes.”
• Distinguish endocrine islets from exocrine pancreas and identify α- and β-cells. • Trace the effects of insulin and glucagon on liver, adipose and muscle metabolism. • Explain negative-feedback maintenance of glucose levels during feeding and fasting. • Distinguish diabetes mellitus from diabetes insipidus and recognise the relevance of insulin resistance.
Why must the body maintain available blood glucose?
Glucose is a major metabolic fuel. The brain and red blood cells rely heavily on blood-borne glucose under ordinary conditions, while muscle and other tissues use it according to need and availability. After a meal, glucose enters blood from the gut and concentrations rise. Between meals, the intestine is no longer supplying as much glucose, so the liver must maintain an adequate supply. The pancreatic islets coordinate both situations by secreting hormones whose major effects on blood glucose oppose one another.
Pancreas combines digestion and endocrine regulation
The pancreas is a composite organ. Exocrine acinar cells secrete digestive enzymes into ducts leading to the intestine, whereas endocrine islets of Langerhans secrete hormones directly into surrounding blood vessels. The source describes roughly 1–2 million islets in a typical human pancreas, forming only about 1–2% of its tissue. Islets contain several cell types, but the source emphasises α (alpha) cells, which produce glucagon, and β (beta) cells, which produce insulin. Their close position permits rapid adjustment of hormone release when circulating nutrients change.
A cluster of hormone-producing endocrine cells within the pancreas, including glucagon-producing α cells and insulin-producing β cells.
Glucagon is a response to reduced available glucose
A pancreatic peptide hormone released by α cells that generally increases blood glucose, especially by acting on the liver.
When fasting lowers circulating glucose, alpha-cell glucagon secretion tends to increase. The liver contains glycogen, a stored polymer of glucose. Glucagon activates signalling pathways that promote glycogenolysis—the breakdown of glycogen—releasing glucose into blood. It also increases hepatic gluconeogenesis, production of new glucose from precursors such as lactate, glycerol and suitable amino acids. Both actions contribute to restoring blood glucose when intestinal absorption has declined.
Glucagon is therefore described as a hyperglycaemic hormone: it raises blood glucose. This does not mean glucagon is pathological or that any increase it causes constitutes diabetes. A coordinated increase during a fast is a normal physiological response. The source also mentions reduced glucose utilisation in certain contexts; the central direct target in this discussion is liver metabolism, not a claim that glucagon uniformly blocks glucose entry in every tissue.
Insulin responds to available nutrients
A peptide hormone secreted by pancreatic β cells that supports glucose uptake, use and storage and generally lowers elevated blood glucose.
When glucose levels increase after a meal, pancreatic beta cells release insulin. In skeletal muscle and adipose tissue, insulin stimulates movement of GLUT4 glucose transporters to cell membranes, increasing glucose uptake. It also promotes glycogen synthesis and storage in liver and muscles, encourages nutrient storage and reduces hepatic glucose production. Together these actions return elevated glucose toward a suitable range while providing energy and storing reserves.
A useful scientific nuance is that glucose enters liver cells through largely insulin-independent GLUT2 transport, whereas insulin regulates what hepatocytes do with glucose through enzymes and gene activity. The source describes enhanced glucose uptake and utilisation by hepatocytes and adipocytes; the physiological conclusion that insulin lowers glucose is correct, but the mechanisms of uptake differ between liver and muscle/adipose. For a school-level understanding, focus on increased utilisation/storage and reduced liver glucose output.
Negative feedback maintains glucose homeostasis
Insulin and glucagon are not simply turned on and off permanently. Their amounts vary continuously with circulating nutrients, nervous inputs and other hormones. Rising glucose stimulates insulin and restrains glucagon in many contexts; insulin increases uptake/storage while reducing hepatic output. Falling glucose shifts the balance toward glucagon and hepatic glucose release. These responses oppose deviations from a workable range, an example of negative feedback. Real glucose curves fluctuate and are not perfectly flat.
| Feature | Insulin | Glucagon |
|---|---|---|
| Secretory cell | Pancreatic β cell | Pancreatic α cell |
| Typical stimulus | Rising glucose after feeding | Falling glucose during fasting |
| Main effect on blood glucose | Lowers elevated glucose | Raises glucose |
| Liver effect | Promotes glycogenesis and reduces glucose output | Stimulates glycogenolysis and gluconeogenesis |
| Major peripheral effects | Promotes muscle/adipose uptake and storage | Chiefly hepatic glucose mobilisation |
| Physiological role | Post-meal nutrient utilisation and storage | Maintaining fuel supply between meals |
Diabetes mellitus involves impaired insulin action
A group of metabolic disorders characterised by persistent elevated blood glucose owing to insufficient insulin secretion, ineffective insulin action or both.
If the pancreas produces very little insulin, or tissues respond inadequately to insulin, blood glucose can remain abnormally high. When glucose exceeds the kidney's capacity to reclaim filtered glucose, glucose may appear in urine and draw extra water with it, producing increased urination and thirst. Severe insulin deficiency can also favour fat breakdown and accumulation of ketone bodies, leading in some settings to dangerous ketoacidosis. These effects explain why diabetes can involve far more than a high number on a blood test.
The source stresses insulin treatment, which is essential in type 1 diabetes and may also be required in other forms. Type 1 usually involves substantial destruction or loss of pancreatic beta cells and absolute insulin deficiency. Type 2 commonly combines resistance to insulin's action with progressive limitations in beta-cell function. These modern distinctions clarify why not every patient with diabetes has identical physiology or treatment; medication decisions belong to clinical professionals, not this educational lesson.
Do not confuse mellitus with insipidus
Diabetes mellitus involves glucose dysregulation and may produce glucose-containing urine. Diabetes insipidus, discussed with ADH, involves inadequate action of vasopressin on kidney water conservation and causes large amounts of dilute urine without hyperglycaemia as its defining mechanism. The shared symptom of high urine output does not establish that these are the same disease. Always identify whether the primary disrupted variable is glucose handling or water balance.
A hormone that normally raises blood glucose is not necessarily 'bad'; glucagon is required during fasting. A hormone that normally lowers glucose is not enough by itself to diagnose disease or determine treatment.
Quick Quiz
Quiz
Which islet cells synthesise insulin?
Which islet cells secrete glucagon?
Which process is directly stimulated by glucagon in liver?
What does insulin generally do after a meal?
GLUT4 transporters are particularly important in insulin-stimulated uptake by:
What is glycogenesis?
Which is a cause of diabetes mellitus?
Which is a common result of persistent severe hyperglycaemia?
How is diabetes insipidus fundamentally different?
Practice Problems
- Draw a two-branch feedback chart for elevated and reduced glucose.
- Compare α-cell glucagon and β-cell insulin in their effects on liver metabolism.
- Explain why the pancreas is both endocrine and exocrine.
- What causes excessive urination in diabetes mellitus and how does it differ from diabetes insipidus?
- Explain the roles of insulin deficiency and insulin resistance in two common forms of diabetes.
Elevated blood glucose stimulates pancreatic β-cell insulin → muscle/adipose glucose uptake, liver storage and reduced output → glucose falls. Lower glucose stimulates α-cell glucagon → hepatic glycogenolysis and gluconeogenesis → glucose rises.
Key Takeaways
• Pancreatic α cells release glucagon and β cells release insulin. • Glucagon raises blood glucose through liver glycogenolysis and gluconeogenesis. • Insulin promotes glucose utilisation and storage and suppresses liver glucose output. • Insulin and glucagon act as a negative-feedback system maintaining metabolic homeostasis. • Diabetes mellitus results from impaired insulin availability/action; diabetes insipidus is a distinct ADH-related water disorder.